Advanced search×

Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.

M P MP Carrieri, J P JP Moatti, D D Vlahov, Y Y Obadia, C C Reynaud-Maurupt, and M M Chesney

J Epidemiol Community Health 53(1):4-8 (1999) PMID 10326045 PMCID 1756774

To determine the influence of continued drug use and its perception by prescribing physicians on access to antiretroviral treatment among French HIV infected injection drug users (IDUs).

Version: za2963e q8zab q8zb1 q8zcc q8zde q8ze9 q8zf2 q8zga
View PDF

Similar articles you may find interesting…

  1. Single-platform, volumetric, CD45-assisted pan-leucogating flow cytometry for CD4 T lymphocytes monitoring of HIV infection according to the...
    Donato Koyalta, Mohammad-Ali Jenabian, and Laurent Bélec

    BMC Res Notes 6(1):169 (2013) PMID 23631664

    Absolute and percentage CD4 T cell counts obtained by Auto40 and FACSCalibur of 258 HIV-1-infected blood samples were highly correlated (r = 0.99 and r = 0.96, respectively). The mean absolute bias and percent bias between Apogee Auto40 and FACSCalibur absolute CD4 T cell counts, were -9.4 cells/mul...
    PDF not found
  2. Retrospective Real-World Adherence in Patients With Type 2 Diabetes Initiating Once-Daily Liraglutide 1.8 mg or Twice-Daily Exenatide 10 μg.
    Maria Malmenäs, Jonathan R Bouchard, and Jakob Langer

    Clin Ther (2013) PMID 23642290

    This study found that adherence to once-daily liraglutide 1.8 mg treatment was superior to twice-daily exenatide 10 μg over a 12-month follow-up period. Nonadherence has important implications to the health care system, both in terms of clinical effectiveness and economic burden (eg, hospitalizatio...
    Buy PDF
  3. The dual effect of MSCs on tumour growth and tumour angiogenesis.
    Michelle Kéramidas, Florence de Fraipont, and Claire Rome

    Stem Cell Res Ther 4(2):41 (2013) PMID 23628074

    Our results suggest that hMSCs injection decreased solid tumour growth in mice and modified tumour vasculature, which confirms hMSCs could be interesting to use for the treatment of pre-established tumours....
    PDF not found